Kala Pharmaceuticals

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary mucus-penetrating particle technology, with a focus on the treatment of eye diseases. Kala’s first product, INVELTYS® for the treatment of inflammation and pain following ocular surgery, was approved in 2019 and its lead product candidate, KPI-121 0.25%, for the temporary relief of the signs and symptoms of dry eye disease is in phase III trials
 
 
Kala
 

Details
Kala Pharmaceuticals, Inc.
490 Arsenal Way, Suite 120
Watertown, MA 02472
USA
www.kalarx.com